Jiangxi Fushine Pharmaceutical Co Ltd (300497) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.31 Million ≈ $2.68 Million USD) by net assets (CN¥2.17 Billion ≈ $317.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Jiangxi Fushine Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

Jiangxi Fushine Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Jiangxi Fushine Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Jiangxi Fushine Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Jiangxi Fushine Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangxi Fushine Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sino Prima Gas Technology Co Ltd SHE:300483	0.136x
Fsilon Furnishing and Construction Materials Corp SHG:605318	0.036x
Ruyizhou Inc NYSE:RYZ	0.148x
Ingenia Communities Group AU:INA	0.045x
Shunsin Technology Holdings Ltd TW:6451	-0.044x
Jamieson Wellness Inc TO:JWEL	0.014x
Shanghai Electric Group Company Limited F:USR	0.061x
Titagarh Rail Systems Limited NSE:TITAGARH	0.073x

Annual Cash Flow Conversion Efficiency for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Jiangxi Fushine Pharmaceutical Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.20 Billion ≈ $321.96 Million	CN¥62.67 Million ≈ $9.17 Million	0.028x	-66.95%
2024-12-31	CN¥2.18 Billion ≈ $318.55 Million	CN¥187.64 Million ≈ $27.46 Million	0.086x	+428.84%
2023-12-31	CN¥2.47 Billion ≈ $361.55 Million	CN¥-64.76 Million ≈ $-9.48 Million	-0.026x	+41.66%
2022-12-31	CN¥2.69 Billion ≈ $393.58 Million	CN¥-120.85 Million ≈ $-17.68 Million	-0.045x	-280.87%
2021-12-31	CN¥2.91 Billion ≈ $426.02 Million	CN¥72.32 Million ≈ $10.58 Million	0.025x	-80.20%
2020-12-31	CN¥3.05 Billion ≈ $445.98 Million	CN¥382.35 Million ≈ $55.95 Million	0.125x	-43.29%
2019-12-31	CN¥1.53 Billion ≈ $223.52 Million	CN¥337.91 Million ≈ $49.45 Million	0.221x	+44.20%
2018-12-31	CN¥1.15 Billion ≈ $167.80 Million	CN¥175.91 Million ≈ $25.74 Million	0.153x	-29.62%
2017-12-31	CN¥966.71 Million ≈ $141.46 Million	CN¥210.72 Million ≈ $30.84 Million	0.218x	-9.34%
2016-12-31	CN¥784.17 Million ≈ $114.75 Million	CN¥188.53 Million ≈ $27.59 Million	0.240x	+93.69%
2015-12-31	CN¥596.21 Million ≈ $87.24 Million	CN¥74.01 Million ≈ $10.83 Million	0.124x	+12.02%
2014-12-31	CN¥283.26 Million ≈ $41.45 Million	CN¥31.39 Million ≈ $4.59 Million	0.111x	-55.50%
2013-12-31	CN¥229.76 Million ≈ $33.62 Million	CN¥57.22 Million ≈ $8.37 Million	0.249x	-27.25%
2012-12-31	CN¥184.60 Million ≈ $27.01 Million	CN¥63.20 Million ≈ $9.25 Million	0.342x	+22.08%
2011-12-31	CN¥120.52 Million ≈ $17.64 Million	CN¥33.80 Million ≈ $4.95 Million	0.280x	--

About Jiangxi Fushine Pharmaceutical Co Ltd

SHE:300497 China Biotechnology

Market Cap

$1.25 Billion

CN¥8.56 Billion CNY

Market Cap Rank

#7857 Global

#1752 in China

Share Price

CN¥15.90

Change (1 day)

-3.11%

52-Week Range

CN¥9.75 - CN¥23.34

All Time High

CN¥24.76